Palmero, Lolita M.
HRN: 21-71-75 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/01/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/01/2022
08/08/2022
IV
500
Q8h
Acute Cholecystitis
Waiting Final Action
Indication: Prophylaxis Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes